Related Tags >> vaccine Gardasil AIDS vaccine cervical cancer

Merck News

Most Popular Merck Story

CDC expands recommendations for Merck's PPV vax

October 23, 2008 — 3:21pm ET | By Calisha Myers

Adults smokers ages 19 to 64, or those in that age group with asthma, should receive the pneumococcal polysaccharide vaccine (PPV), according to the CDC's Advisory Committee on Immunization Practices... Read more...

Merck Press Releases

Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors
Merck Announces Voluntary Delisting from Philadelphia Stock Exchange
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
CDC Advisory Panel Votes to Update Pneumococcal Vaccination Recommendations
Merck Reports Third-Quarter 2008 Financial Results

Latest Headlines

Merck plans big vaccine expansion in India
November 20, 2008
In Phase III, Gardasil prevents HPV in men
November 13, 2008
T-cell HIV vax still promising
November 12, 2008
HPV researcher calls for vaccination of males
November 10, 2008
Merck starts work on vax R&D center
November 6, 2008
HIV vax debacle linked to T-cell activation
November 6, 2008
Rotavirus vax draws rave review at annual gathering
October 28, 2008
CDC expands recommendations for Merck's PPV vax
October 23, 2008
Merck eyes big shares of Indian vax market
October 23, 2008
Critics accuse Merck of hyping cervical cancer risk
August 21, 2008
Study examines cost-effectiveness of Gardasil
August 21, 2008
Merck, Dynavax announce Heplisav results
August 6, 2008
Merck invests $300M in vaccine expansion
July 24, 2008
Wall Street shrugs off FDA’s Gardasil rejection
June 26, 2008
Merck’s rotavirus vaccine makes big impact
June 26, 2008
Planned AIDS vaccine trial raises concerns
June 5, 2008
FDA orders Merck to fix vaccine plant problems
May 1, 2008
Feds steering funds back to basic AIDS vax research
March 27, 2008

Paid Research Reports